US Pharma MarketingThe post The biggest opportunity to improve lung cancer survival isn’t a new drug appeared first on Medical Device Network.
The biggest opportunity to improve lung cancer survival isn’t a new drug
Chris Wood, CEO of RevealDx, reflects on the role AI-based characterisation of nodules (CADx) has to play in improving lung cancer survival rates. The post The biggest opportunity to improve lung cancer survival isn’t a new drug appeared first on Medical Device Network .
Chris Wood, CEO of RevealDx, reflects on the role AI-based characterisation of nodules (CADx) has to play in improving lung cancer survival rates.
Source: Medical Device Network